EP Patent

EP3375778A1 — Aryl-piperidine derivatives

Assigned to Artax Biopharma Inc · Expires 2018-09-19 · 8y expired

What this patent protects

An aryl-piperidine derivative of formula I, wherein the meaning of R 3 , X, C z and Cy is that specified in the description, for use as inhibitors of T cells.

USPTO Abstract

An aryl-piperidine derivative of formula I, wherein the meaning of R 3 , X, C z and Cy is that specified in the description, for use as inhibitors of T cells.

Drugs covered by this patent

Patent Metadata

Patent number
EP3375778A1
Jurisdiction
EP
Classification
—
Expires
2018-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Artax Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.